Retractable Technologies Change in Accounts Payable 2010-2024 | RVP

Retractable Technologies change in accounts payable from 2010 to 2024. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Retractable Technologies Annual Change in Accounts Payable
(Millions of US $)
2024 $0
2023 $-2
2022 $-14
2021 $4
2020 $11
2019 $0
2018 $0
2017 $0
2016 $-1
2015 $1
2014 $0
2013 $0
2012 $1
2011 $1
2010 $-4
2009 $1
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.033B
Retractable Technologies, Inc. designs, develops, manufactures, and markets innovative patented safety needle devices for the healthcare industry.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $85.362B 20.61
Becton Dickinson (BDX) United States $49.016B 12.14
Cardinal Health (CAH) United States $35.422B 18.55
Straumann Holding AG (SAUHY) Switzerland $21.335B 0.00
Labcorp (LH) United States $20.286B 16.45
Cooper (COO) United States $16.092B 21.34
West Pharmaceutical Services (WST) United States $14.850B 31.13
Align Technology (ALGN) United States $13.602B 27.00
Henry Schein (HSIC) United States $8.530B 14.63
Merit Medical Systems (MMSI) United States $5.733B 27.72
DENTSPLY SIRONA (XRAY) United States $3.278B 9.79
CONMED (CNMD) United States $1.814B 13.57
STAAR Surgical (STAA) United States $0.863B 0.00
Lifevantage (LFVN) United States $0.158B 16.31
Pro-Dex (PDEX) United States $0.141B 15.48